Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.32 |
| ▸ | CES2 | O00748 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.31 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7951931 | 0.85 | TSHR (0.37) | TSHRMEN1KMT2ACYP3A4THRB | |
| SCHEMBL25186147 | 0.81 | — | — | |
| SCHEMBL5702358 | 0.81 | FAAH (0.42) | TSHRMEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL3792898 | 0.81 | FAAH (0.42) | TSHRMEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL18496517 | 0.81 | FAAH (0.42) | TSHRMEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL11135210 | 0.78 | LMNA (0.46) | TSHRMEN1KMT2ACYP3A4THRB | |
| SCHEMBL22289437 | 0.76 | PAOX (0.34) | — | |
| SCHEMBL28424610 | 0.74 | DGKA (0.52) | TSHRMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL28418419 | 0.74 | DGKA (0.52) | TSHRMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL27941728 | 0.72 | TSHR (0.55) | TSHRTHRBALDH1A1EPHX1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003104304-A1 | METHOD FOR MAKING SILOXANE POLYMERS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2003-12-18 | — | — | WO | disclosed |
| US-20030232951-A1 | Preparation of low loss optical material from difunctional silyl enol ethers and difunctional silanols | AUSTRALIAN NATIONAL UNIVERSITY, THE (AU) | 2003-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232951-A1 | Preparation of low loss optical material from difunctional silyl enol ethers and difunctional silanols | CNKSR1, CCNL2, SAAL1 | TSHR 3837/4885MEN1 3097/4885KMT2A 1504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.